Ifosfamide
Not Tagged
['sarcoma']
study finds high-dose ifosfamide superior to other standard-of-care treatments in recurrent and primary refractory ewing sarcomas #sarcoma #oncology #cancer #asco22
News and views from the world of clinical oncology and hematology